Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Country - Poland
Summary - Zp/60/Tp/25 Delivery Of The Obinutuzumab Drug For A Non-Commercial Clinical Trial For The Experimental Arm Of Avo-Cll Financed By The Medical Research Agency As Part Of The Project Entitled “The Avo-Cll Study: A Multicenter, Randomized, Open-Label, Phase 3 Study Comparing The Efficacy And Safety Of Acalabrutinib In Combination With Obinutuzumab Compared To Venetoclax In Combination With Obinutuzumab In The First-Line Treatment Of Newly Diagnosed Chronic Lymphocytic Leukemia”
Deadline - Oct 31, 2025
GT reference number - 120819263
Product classification - Pharmaceutical products
Address - Poland
Contact details - 565656565
Tender notice no. - 76454545
GT Ref Id - 120819263
Document Type - Tender Notices
Description - Description: Ladies and Gentlemen, documentation related to the procedure is included in the annexes to the procedure. Instructions for submitting offers/applications for Contractors are available at the link. Files attached to the form should inclu de:- qualified electronic signature,- trusted signature,- or electronic personal signature. Due to the above, the form on this website is used to submit an offer with attachments, while the "Send a message to the ordering party" button is used to: Asking questions to the Ordering Party,Responses to requests to supplement the offer or provide explanations,Submissions of appeals/other. Pursuant to Art. 61. paragraph 1. and art. 63 section 2 of th
Gt Ref Id - 120819263
Deadline - Oct 31, 2025
Similar Tenders :
|
Summary:
|
|
Summary:
|
Join to access thousands of business opportunities
Why Us
3,00,000 +
Users
190 +
Countries Covered
5,00,000 +
Agencies Tracked
50,000 +
Notices Daily
90 Million +
Database
